Republicans slash FDA budget; Pakistan commits to biosimilars;

> House Republicans cut millions of dollars last week from the FDA's budget. Story

> Pakistan's first National Pharma Summit has resolved to support the country's universities and science and centers engaged in bio-equivalence studies. Story

> TruTag Technologies earned the "most likely to succeed" honor in the Life Science session at the Launch: Silicon Valley 2011 conference for its covert, low-cost, heat-resistant and edible silica microtag for improved tracking of clinical trial supplies. Announcement

> The Bombay Stock Exchange said it will add Sun Pharmaceutical in the 30-stock benchmark Sensex. Item

> GlaxoSmithKline will purchase Shenzhen Neptunus' stake in a venture among companies developing and manufacturing flu vaccines in China, Hong Kong and Macau. Story

> Aseptic filling specialist Vetter has installed three lyophilizers, nearly doubling the freeze-drying capacity at its Ravensburg Vetter South facility in Germany. Release

> University of Pittsburgh engineers have developed an RFID-based system for enhanced track/trace of orthopedic implants. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.